Positioning Intelligence

Short Interest Intelligence

Reported short interest, days to cover, price reaction, sector pressure, squeeze risk, bearish conviction, and where positioning is fighting the tape.

Latest settlement 30 Jun 2026 Updated 12 Jul 2026 12:36

Signal Design

Not just “high short interest”

We score the latest reported short position against its own history, then compare that crowding with days to cover, price movement since the prior report, and Sharemaestro trend context. The result is a research map, not a trade recommendation.

The aim is to show where positioning is crowded, confirmed, trapped, or unwinding, so the user can build a better shortlist before doing ticker-level work.

Squeeze PressureShorts are crowded while price or trend is improving.
Bearish ConvictionShorts are adding while price action confirms weakness.
DivergenceShort positioning and price action are disagreeing.
CoveringShorts are reducing exposure as price rises.
Reset

Setup Distribution

classification mix
Neutral1987 names
Squeeze Pressure1261 names
Crowded Short1154 names
Bearish Conviction417 names
Positioning Divergence189 names
Covering Rally44 names

Positioning Map

short positioning versus price reaction
Shorts under pressureShort positioning increased while price rose.
1703
Shorts being confirmedShort positioning increased while price weakened.
1117
Covering into strengthShort positioning fell while price rose.
1118
Bearish pressure easingShort positioning fell while price also weakened.
1106

Radar Table

Current Short-Interest Reads

Showing 3151-3180 of 5031
StockSetupScoreShort interestChangeDays coverPrice reactionTrend
GSBDGoldman Sachs BDC Inc Positioning Divergence 58 7.8M +8.2% 8.29 +2.5% Mixed
EEExcelerate Energy Inc Positioning Divergence 58 2.2M +10.1% 4.54 +10.1% Mixed
MDAISpectral AI Inc. Positioning Divergence 58 2.3M -21.6% 7.11 -6.0% Improving
NJRNewJersey Resources Corporation Positioning Divergence 58 3.7M +39.0% 3.31 +4.6% Mixed
NTZNatuzzi SpA Positioning Divergence 58 542 -61.4% 1.84 -13.5% Weak
SWIMLatham Group Inc Neutral 58 3.9M -2.7% 3.62 +14.5% Constructive
VBIOValion Bio Inc Neutral 58 155.2K -40.4% 1.00 -1.9% Improving
ASTEAstec Industries Inc Positioning Divergence 58 548.0K +9.3% 2.23 +18.9% Mixed
ADGMAdagio Medical Holdings, Inc Common Stock Positioning Divergence 58 60.2K -13.8% 1.00 -13.3% Weak
FORForestar Group Inc Neutral 58 535.0K +4.0% 3.29 +9.4% Constructive
JILLJ.Jill Inc Neutral 58 570.9K +6.7% 7.10 +8.1% Constructive
ORICOric Pharmaceuticals Inc Positioning Divergence 58 22.1M +5.0% 12.32 +15.2% Weak
CRVSCorvus Pharmaceuticals Inc Positioning Divergence 58 18.8M +5.2% 12.38 +13.1% Weak
TVRDTvardi Therapeutics, Inc. Neutral 58 507.4K +27.5% 1.00 -43.2% Improving
AQSTAquestive Therapeutics Inc Neutral 58 16.0M +8.1% 5.28 +5.3% Constructive
ALMSAlumis Inc Positioning Divergence 58 14.3M +12.9% 7.56 +9.3% Mixed
PGRProgressive Corp Neutral 58 7.8M +2.0% 1.68 +10.5% Constructive
AGCOAGCO Corporation Positioning Divergence 58 2.8M +6.1% 3.78 +4.3% Mixed
ALISCalisa Acquisition Corp Ordinary shares Neutral 58 876 +37.3% 1.00 +0.2% Constructive
WGOWinnebago Industries Inc Positioning Divergence 58 3.1M +29.5% 2.54 +7.2% Weak
TJGCTJGC Group Limited Positioning Divergence 58 108.6K -12.8% 1.00 -16.3% Constructive
NCINeo-Concept International Group Holdings Limited Ordinary Shares Positioning Divergence 58 34.5K +41.5% 1.00 +4.5% Weak
OLMAOlema Pharmaceuticals Inc Positioning Divergence 58 14.0M +9.3% 5.68 +15.4% Weak
NPKINPK International Inc. Positioning Divergence 58 2.5M +21.3% 1.54 +4.2% Mixed
RPRXRoyalty Pharma Plc Neutral 58 12.4M +11.8% 2.98 +2.5% Constructive
ALABAstera Labs, Inc. Neutral 58 12.7M +10.1% 1.74 +6.7% Constructive
PDLBPonce Financial Group Inc Neutral 58 313.9K +15.9% 2.95 +1.8% Constructive
AUPHAurinia Pharmaceuticals Inc Neutral 58 9.6M +3.6% 3.88 +8.9% Constructive
LOOPLoop Industries Inc Neutral 58 416.8K +8.0% 4.86 -12.7% Weak
NVXNovonix Ltd ADR Neutral 58 4.1M +2.4% 9.36 -34.9% Weak

Short interest is delayed, reported twice monthly, and shown for educational research only. It does not prove buyer or seller intent, and it is not financial advice.